10x Genomics Inc (NASDAQ: TXG) is -74.77% lower on its value in year-to-date trading and has touched a low of $14.02 and a high of $57.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TXG stock was last observed hovering at around $14.91 in the last trading session, with the day’s loss setting it -0.79%.
Currently trading at $14.12, the stock is -10.53% and -24.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.25 million and changing -5.30% at the moment leaves the stock -46.07% off its SMA200. TXG registered -64.58% loss for a year compared to 6-month loss of -44.82%. The firm has a 50-day simple moving average (SMA 50) of $18.7678 and a 200-day simple moving average (SMA200) of $26.3176.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.29% gain in the last 1 month and extending the period to 3 months gives it a -35.08%, and is -12.68% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.93% over the week and 5.76% over the month.
10x Genomics Inc (TXG) has around 1259 employees, a market worth around $1.71B and $629.74M in sales. Profit margin for the company is -28.99%. Distance from 52-week low is 0.71% and -75.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.84%).
The EPS is expected to grow by 35.26% this year
373.0 institutions hold shares in 10x Genomics Inc (TXG), with institutional investors hold 94.42% of the company’s shares. The shares outstanding are 105.04M, and float is at 100.17M with Short Float at 7.60%. Institutions hold 92.38% of the Float.
The top institutional shareholder in the company is FMR LLC with over 13.01 million shares valued at $253.05 million. The investor’s holdings represent 10.8971 of the TXG Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.19 million shares valued at $198.18 million to account for 8.5341 of the shares outstanding. The other top investors are ARK INVESTMENT MANAGEMENT LLC which holds 9.31 million shares representing 7.8009 and valued at over $181.15 million, while BLACKROCK INC. holds 5.3542 of the shares totaling 6.39 million with a market value of $124.34 million.
10x Genomics Inc (TXG) Insider Activity
The most recent transaction is an insider sale by Saxonov Serge, the company’s Chief Executive Officer. SEC filings show that Saxonov Serge sold 6,749 shares of the company’s common stock on Aug 22 ’24 at a price of $22.53 per share for a total of $0.15 million. Following the sale, the insider now owns 0.88 million shares.
10x Genomics Inc disclosed in a document filed with the SEC on Aug 22 ’24 that Hindson Benjamin J. () sold a total of 4,351 shares of the company’s common stock. The trade occurred on Aug 22 ’24 and was made at $22.53 per share for $98027.0. Following the transaction, the insider now directly holds 0.35 million shares of the TXG stock.
Still, SEC filings show that on Aug 22 ’24, McAnear Justin J. (Former Chief Financial Officer) disposed off 2,961 shares at an average price of $22.53 for $66710.0. The insider now directly holds 143,242 shares of 10x Genomics Inc (TXG).
